Kintor Pharmaceutical Limited
KNTPF
$0.3643
$0.034910.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.37M | 21.20M | 45.93M | 46.22M | 64.60M |
| Total Receivables | 2.14M | 2.23M | 1.87M | 1.88M | 913.80K |
| Inventory | 303.50K | 315.80K | 27.50K | 27.70K | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 709.70K | 738.50K | 3.28M | 3.30M | 1.13M |
| Total Current Assets | 23.53M | 24.48M | 51.10M | 51.43M | 66.64M |
|
|
|||||
| Total Current Assets | 23.53M | 24.48M | 51.10M | 51.43M | 66.64M |
| Net Property, Plant & Equipment | 23.87M | 24.84M | 26.34M | 26.51M | 31.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 20.41M | 21.23M | 20.50M | 20.64M | 21.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 499.40K | 519.60K | 1.35M | 1.36M | 1.11M |
| Total Assets | 70.57M | 73.44M | 101.77M | 102.42M | 122.58M |
|
|
|||||
| Total Accounts Payable | 5.61M | 5.84M | 7.02M | 7.07M | 11.51M |
| Total Accrued Expenses | 915.50K | 952.60K | 724.20K | 728.90K | 2.44M |
| Short-term Debt | 1.97M | 2.05M | 2.75M | 2.77M | 2.82M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.51M | 14.06M | 21.87M | 22.01M | 13.85M |
| Total Finance Division Other Current Liabilities | 826.40K | 859.90K | 420.30K | 423.00K | 1.07M |
| Total Other Current Liabilities | 826.40K | 859.90K | 420.30K | 423.00K | 1.07M |
| Total Current Liabilities | 22.84M | 23.76M | 32.79M | 33.00M | 31.69M |
|
|
|||||
| Total Current Liabilities | 22.84M | 23.76M | 32.79M | 33.00M | 31.69M |
| Long-Term Debt | 2.74M | 2.85M | 8.15M | 8.20M | 18.81M |
| Short-term Debt | 1.97M | 2.05M | 2.75M | 2.77M | 2.82M |
| Capital Leases | -- | -- | 97.30K | 97.90K | 322.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.71M | 4.90M | 6.85M | 6.90M | 7.15M |
| Total Liabilities | 30.28M | 31.51M | 47.88M | 48.19M | 57.98M |
|
|
|||||
| Common Stock & APIC | 576.85M | 600.25M | 582.34M | 586.08M | 589.78M |
| Retained Earnings | -539.79M | -561.69M | -530.65M | -534.06M | -533.74M |
| Treasury Stock & Other | 3.23M | 3.36M | 2.19M | 2.21M | 8.56M |
| Total Common Equity | 40.29M | 41.92M | 53.88M | 54.23M | 64.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 40.29M | 41.92M | 53.88M | 54.23M | 64.61M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 40.29M | 41.92M | 53.88M | 54.23M | 64.61M |
|
|
|||||